April 22, 2014 | Israeli company Brainsway, which develops non-invasive treatments using transcranial magnetic stimulation (TMS), has reported positive results in a small trial for the treatment of Parkinson’s Disease. The trial was done at the San Raffaelle medical center in Milan, italy, and included 60 patients, which is not a large-enough test group for conclusive results.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments